Revefenacin trihydrate

Revefenacin Trihydrate is used to treat Chronic Obstructive Pulmonary Disease (COPD). It is a long-acting muscarinic antagonist (LAMA) designed for once-daily inhalation therapy. It is grouped under the following drug class(es): Bronchodilators. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include CB9J2CKN88. Its PubChem CID is 171390019.

CAS No N/A
Molecular Formula C35H49N5O7
Molecular Weight 651.8 g/mol
Synonyms [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate;trihydrate

Frequently Asked Questions